Clinical Value of Iodine-123 Beta-Methyliodophenyl Pentadecanoic Acid (BMIPP) Myocardial Single Photon Emission Computed Tomography for Predicting Cardiac Death Among Patients With Chronic Heart Failure

  • Sasaki Ryu
    Division of Cardiology, Fujisawa Municipal Hospital
  • Mitani Isao
    Second Department of Internal Medicine, Yokohama City University School of Medicine
  • Usui Takashi
    Division of Cardiology, Fujisawa Municipal Hospital
  • Kitamura Yutaka
    Division of Cardiology, Yokosuka Municipal Hospital
  • Yoshii Yuzuru
    Division of Cardiology, Saiseikai Yokohama Nanbu Hospital
  • Ishikawa Toshiyuki
    Second Department of Internal Medicine, Yokohama City University School of Medicine
  • Uchino Kazuaki
    Second Department of Internal Medicine, Yokohama City University School of Medicine
  • Takahashi Nobukazu
    Second Department of Internal Medicine, Yokohama City University School of Medicine
  • Kimura Kazuo
    Second Department of Internal Medicine, Yokohama City University School of Medicine
  • Umemura Satoshi
    Second Department of Internal Medicine, Yokohama City University School of Medicine

この論文をさがす

抄録

In the present study, the effectiveness of 123I-β-methyliodophenyl pentadecanoic acid (BMIPP) single photon emission computed tomography (SPECT) for predicting cardiac death of patients with chronic heart failure was evaluated. Abnormalities of fatty acid metabolism are found in patients with chronic heart failure and BMIPP was developed as a tracer for scintigraphic assessment of myocardial fatty acid utilization. The study group comprised 74 patients with chronic heart failure with a left ventricular ejection fraction (LVEF) <45% on left ventriculography or radionuclide angiocardiography. They underwent both 201Tl SPECT and BMIPP SPECT. The uptake of tracer was scored semiquantitatively from 0 (normal) to 4 (defect) in 20 segments and a total defect score (TDS) for all 20 segments was calculated. On planar images the mediastinum to heart count ratio (H/M) was calculated for the BMIPP and Tl studies, and the H/MBMIPP:H/MTl (H/MBMIPP divided by H/MTl) was also calculated. The mean follow-up period was 660 days and there were 17 cases of cardiac death. Multivariate analysis identified H/MBMIPP:H/MTl (p<0.05) and LVEF (p<0.05) as independent predictors of cardiac death. The receiver-operating characteristic curve of H/MBMIPP:H/M Tl was situated to the left relative to LVEF. Analysis of the myocardial metabolism by BMIPP SPECT can predict the high-risk patients with chronic heart failure. (Circ J 2003; 67: 918 - 924)<br>

収録刊行物

  • Circulation Journal

    Circulation Journal 67 (11), 918-924, 2003

    一般社団法人 日本循環器学会

被引用文献 (4)*注記

もっと見る

参考文献 (54)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ